Showing results (61-70 of 92) with videos related to
Sort By:
Pageof 10
Alimentary Pharmacology & Therapeutics|October 28, 2024
Prevalence of Low FIB-4 in MASLD-Related Hepatocellular Carcinoma: A Multicentre StudyDarren Jun Hao Tan, Nobuharu Tamaki, Beom Kyung Kim, et al.Journal of Clinical and Experimental Hepatology|July 13, 2023
Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD - An Umbrella Overview of Systematic Review of Meta-AnalysisJieling Xiao, Cheng Han Ng, Kai En Chan, et al.Journal of Clinical and Translational Hepatology|November 16, 2022
A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for DyslipidemiaJieling Xiao, Cheng-Han Ng, Yip-Han Chin, et al.Transplantation|October 30, 2023
Impact of Pretransplant Diabetes on Outcomes After Liver Transplantation: An Updated Meta-analysis With Systematic ReviewAnsel Shao Pin Tang, Caitlyn Tan, Wen Hui Lim, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 21, 2022
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysisAnsel Tang, Cheng Han Ng, Poh Hui Phang, et al.The Journal of Clinical Endocrinology and Metabolism|May 19, 2022
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 IndividualsKai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, et al.Clinical and Molecular Hepatology|October 20, 2022
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysisDarren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, et al.Frontiers in Medicine|October 17, 2022
A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)Clarissa Elysia Fu, Cheng Han Ng, Nicholas W S Chew, et al.Clinical and Molecular Hepatology|March 2, 2022
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individualsAnsel Shao Pin Tang, Kai En Chan, Jingxuan Quek, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2025
Impact of Model for End-stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-associated Steatohepatitis Cirrhosis Among Liver Transplant CandidatesWen Hui Lim, Darren Jun Hao Tan, Kartik Mitra, et al.Pageof 10